Press Releases GSK plc

Equities

GSK

GB00BN7SWP63

Market Closed - London S.E. Other stock markets 11:35:18 2024-05-03 am EDT			5-day change	1st Jan Change
1,734 ^GBX	+0.29%		+4.87%	+19.54%

May. 03	GSK : DZ Bank remains Neutral	ZD
May. 03	GSK plc : Back on track

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GSK : Q1 2024 results transcript	May. 02	PU
GSK : Q1 2024 results slides	May. 02	PU
GSK : Q1 2024 results infographic	May. 02	PU
Glaxo: Q1 Earnings Snapshot	May. 01	AQ
US FDA accepts for priority review GSK's application for an expanded indication of Jemperli (dostarlimab) plus chemotherapy to include all adult patients with primary advanced or recurrent endometrial cancer \| GSK	Apr. 24	AQ
GSK : Director/Pdmr Shareholding - Form 6-K	Apr. 19	PU
EAGLE-1 phase III data show potential for gepotidacin as a new oral treatment option for uncomplicated urogenital gonorrhoea (GC) amid growing resistance to existing treatments \| GSK	Apr. 17	AQ
New long-term data show Shingrix continues to provide high protection against shingles in adults aged 50 and over for more than a decade \| GSK	Apr. 17	AQ
GSK : EAGLE-1 phase III data show potential for gepotidacin as a new oral treatment option for uncomplicated urogenital gonorrhoea (GC) amid growing resistance to existing treatments - Form 6-K	Apr. 17	PU
GSK's 5-in-1 meningococcal ABCWY vaccine candidate accepted for regulatory review by US FDA \| GSK	Apr. 17	AQ
GSK : EAGLE-1 phase III data show potential for gepotidacin as a new oral treatment option for uncomplicated urogenital gonorrhoea (GC) amid growing resistance to existing treatments	Apr. 17	PU
GSK : New long-term data show Shingrix continues to provide high protection against shingles in adults aged 50 and over for more than a decade	Apr. 17	PU
GSK : 5-in-1 meningococcal ABCWY vaccine candidate accepted for regulatory review by US FDA - Form 6-K	Apr. 16	PU
GSK : 5-in-1 meningococcal ABCWY vaccine candidate accepted for regulatory review by US FDA	Apr. 16	PU
GSK : Q1 2024 pre announcement aide memoire	Apr. 11	PU
WuXi Biologics Reports Solid 2023 Annual Results	Mar. 27	AQ
GSK : Director/Pdmr Shareholding - Form 6-K	Mar. 22	PU
Haleon to buy shares from Pfizer as US pharma giant reduces its stake	Mar. 19	AQ
GSK plc - Positive RUBY phase III data show potential for Jemperli combinations in more patients with primary advanced or recurrent endometrial cancer	Mar. 18	AQ
Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer	Mar. 16	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

GSK plc : Back on track

May 03, 2024 at 05:17 am EDT

GSK PLC : Encouraging start to 2024; guidance raised

May 01, 2024 at 11:38 am EDT